MYC and breast carcinoma: This approach was grounded on our previous bioinformatic and systems biology analyses, where we demonstrated the role of the miR-17/92 cluster in mediating MYC dosage compensation using the NCI-60 panel, 1000 cell lines from the Cancer Cell Line Encyclopedia, and breast cancer tissue data from TCGA [8].